Literature DB >> 30345638

Semi-automated kinetic perimetry: Comparison of the Octopus 900 and Humphrey visual field analyzer 3 versus Goldmann perimetry.

Claudia Bevers1, Gauthier Blanckaert2, Karel Van Keer1,3, Jean-François Fils4, Evelien Vandewalle1,3, Ingeborg Stalmans1,3.   

Abstract

PURPOSE: To evaluate the clinical usefulness and reproducibility of (semi-)automated kinetic perimetry of the Octopus 900 and Humphrey field analyzer 3 (HFA3) compared to Goldmann perimetry as reference technique.
METHODS: A prospective interventional study of two study groups, divided into three subgroups. The first study group consisted of 28 patients, performing one visual field examination on each of the three devices. A second group of 30 patients performed four examinations, one on Goldmann and three on Octopus 900 with the following testing strategies: (1) with reaction time (RT) vector, no headphone; (2) without RT vector, no headphone; and (3) without RT vector, with headphone. Comparisons for V4e and I4e stimuli were made of the mean isopter radius (MIR) and of the distances of the isopter to the central visual axis in four directions. Statistical analysis was made with the R software version 3.2.2.
RESULTS: For V4e stimuli, the mean isopter radius showed no statistic significant difference comparing Goldmann to HFA3 [p-value = 0.144; confidence interval (CI) -0.152 to 0.019] and comparing Goldmann to Octopus 900 without RT vector, either with (p-value = 0.347; CI -0.023 to 0.081) or without headphone (p-value = 0.130; CI -0.011 to 0.095). Octopus 900 with RT vector produced a significantly larger MIR for V4e stimuli in comparison to Goldmann (p-value < 0.001). I4e stimuli produced statistically significantly larger visual field areas when comparing HFA3 and Octopus 900 to Goldmann perimetry.
CONCLUSION: Humphrey field analyzer 3 and Octopus 900 without RT vector are promising successors of Goldmann perimetry.
© 2018 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HFA3; Octopus 900; goldmann perimeter; kinetic perimetry; semi-automated kinetic perimetry

Mesh:

Year:  2018        PMID: 30345638     DOI: 10.1111/aos.13940

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Detailed clinical characterisation, unique features and natural history of autosomal recessive RDH12-associated retinal degeneration.

Authors:  Abigail T Fahim; Zaina Bouzia; Kari H Branham; Neruban Kumaran; Mauricio E Vargas; Kecia L Feathers; N Dayanthi Perera; Kelly Young; Naheed W Khan; John R Heckenlively; Andrew R Webster; Mark E Pennesi; Robin R Ali; Debra A Thompson; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2019-04-12       Impact factor: 4.638

2.  Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults With Retinal Dystrophies.

Authors:  Claire S Barnes; Ronald A Schuchard; David G Birch; Gislin Dagnelie; Leah Wood; Robert K Koenekoop; Ava K Bittner
Journal:  Transl Vis Sci Technol       Date:  2019-06-11       Impact factor: 3.283

3.  Comparative evaluation of Octopus semi-automated kinetic perimeter with Humphrey and Goldmann perimeters in neuro-ophthalmic disorders.

Authors:  Karthika Bhaskaran; Swati Phuljhele; Pawan Kumar; Rohit Saxena; Dewang Angmo; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

4.  Comparison of ZETA Fast (PTS) (Optopol Technology) and Humphrey SITA Fast (SFA) (Carl Zeiss Meditec) Perimetric Strategies.

Authors:  Basil Mathews; Jeff Laux; Cassandra Barnhart; David Fleischman
Journal:  J Ophthalmol       Date:  2022-02-03       Impact factor: 1.909

5.  Visual Field Test With Gaze Check Tasks: Application in a Homonymous Hemianopic Patient Unaware of the Visual Defects.

Authors:  Katsuei Shibuki; Tsuyoshi Yokota; Akane Hirasawa; Daisuke Tamura; Shin Hasegawa; Takashi Nakajima
Journal:  Front Neurol       Date:  2021-06-02       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.